From the IASLC Early Detection and Screening Committee Terminology Issues in Screening and Early Detection of Lung Cancer - IASLC Early Detection and Screening Committee Expert Group Recommendations.
Journal
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235
Informations de publication
Date de publication:
02 Aug 2024
02 Aug 2024
Historique:
received:
30
04
2024
revised:
23
07
2024
accepted:
26
07
2024
medline:
5
8
2024
pubmed:
5
8
2024
entrez:
4
8
2024
Statut:
aheadofprint
Résumé
To facilitate global implementation of lung cancer (LC) screening and early detection in a quality assured and consistent manner, common terminology is needed. Researchers and clinicians within different specialties may use the same terms but with different meanings, or different terms for the same intended meanings. The Diagnostics Working Group of the International Association for the Study of Lung Cancer Early Detection and Screening Committee has analyzed and discussed relevant terms used on a regular basis and suggests recommendations for consensus definitions of terminology applicable in this setting. We explored how to reach consensus to define relevant and unambiguous terminology for use by health care providers, researchers, patients, screening participants and family. Terms and definitions for epidemiological and health-economical purposes included: Standardized incidence and mortality rates, LC specific survival, long-term survival and cure rates, and overdiagnosis, overtreatment, undertreatment. Terms and definitions for defining screening findings included: Positive, false positive, negative, false negative and indeterminate findings and additional and incidental findings. Terms and definitions for describing parameters in screening programmes included: Opportunistic vs programmatic screening, screening rounds, interval/interim diagnoses, invasive and minimally invasive procedures. Terms and definitions for shared decision making included: LC screening - possible harms and risks and LC risk and modifiers prior and posterior to a measure. A common set of terminology with standard definitions is recommended for describing clinical LC screening programmes, the discussion about effectiveness and outcomes, or the clinical setting. The use of the terms should be clearly defined and explained.
Identifiants
pubmed: 39098452
pii: S1556-0864(24)00747-0
doi: 10.1016/j.jtho.2024.07.022
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Investigateurs
Dawei Yang
(D)
Javier Zulueta
(J)
Lucia Viola
(L)
Anant Mohan
(A)
Milena Cavic
(M)
Haval Balata
(H)
Ella Kazerooni
(E)
Ricardo Sales Dos Santos
(R)
Anna Kerpel-Fronius
(A)
Claudia Henschke
(C)
Luigi Ventura
(L)
Long Jiang
(L)
Anne Fraser
(A)
Coenraad Fn Koegelenberg
(CF)
Martin Tammemägi
(M)
Stephen Lam
(S)
Rudolf Huber
(R)
Informations de copyright
Copyright © 2024. Published by Elsevier Inc.